SCHEMBL20534751

SCHEMBL20534751

CCC(C#N)(C(=O)O)c1ccc2c(c1)OCO2

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.42
MAPK1 P28482 1/20 0.42
CRHBP P24387 1/20 0.42
CRHR2 Q13324 1/20 0.42
KIF11 P52732 1/20 0.41
KDM4E B2RXH2 1/20 0.41
GAA P10253 1/20 0.41
CYP3A4 P08684 4/20 0.40
CYP1A2 P05177 3/20 0.40
CYP2C19 P33261 2/20 0.40
MEN1 O00255 1/20 0.40
KMT2A Q03164 1/20 0.40
HPGD P15428 2/20 0.40
MAPT P10636 3/20 0.39
NPC1 O15118 3/20 0.39
RAB9A P51151 3/20 0.39
CYP2D6 P10635 1/20 0.39
CYP2C9 P11712 1/20 0.39
HTT P42858 1/20 0.39
CTNNB1 P35222 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5794655 0.77 ALDH1A1 (0.46) ALDH1A1MAPK1KIF11CYP3A4CYP1A2
SCHEMBL10441731 0.73 ALDH1A1 (0.51) ALDH1A1MAPK1KIF11CYP3A4CYP1A2
SCHEMBL701485 0.73 ALDH1A1 (0.41) ALDH1A1KIF11CYP3A4CYP1A2CYP2C19
SCHEMBL8175237 0.72 ALDH1A1 (0.50) ALDH1A1MAPK1KIF11CYP3A4CYP1A2
SCHEMBL7956195 0.72 CRHBP (0.52) ALDH1A1CRHBPCRHR2KDM4EGAA
SCHEMBL11384727 0.71 CYP3A4 (0.41) ALDH1A1KDM4EGAACYP3A4CYP1A2
SCHEMBL28643060 0.71 ALDH1A1 (0.46) ALDH1A1MAPK1KIF11CYP3A4CYP1A2
SCHEMBL15239119 0.71 KIF11 (0.44) ALDH1A1MAPK1KIF11CYP3A4CYP1A2
SCHEMBL7900944 0.71 CYP2C9 (0.47) ALDH1A1KDM4EHPGDMAPTNPC1
SCHEMBL19265029 0.70 HPGD (0.43) ALDH1A1MAPK1KIF11CYP3A4CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3609869-A1 SUBSTITUTED N-ARYLETHYL-2-ARYLQUINOLINE-4-CARBOXAMIDES AND USE THEREOF Bayer Aktiengesellschaft (DE) 2020-02-19 EP disclosed
WO-2018189011-A1 SUBSTITUTED N-ARYLETHYL-2-ARYLQUINOLINE-4-CARBOXAMIDES AND USE THEREOF BAYER AKTIENGESELLSCHAFT (DE) 2018-10-18 WO disclosed